NCT06931860

Head to Head Trial of Mailed Cologuard to Mailed FIT

Enrolling by Invitation
NAAges 45–49InterventionalScreening
University of California, San Diego
~400 participants
Updated 2025-09-09 on ClinicalTrials.gov
What's tested:CologuardFecal Immunochemical Test

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of Colorectal cancer screening completion
Measured over Within 12 months of randomization
Colorectal Cancer Screening
Fecal Immunochemical Test
Multi-target Stool DNA
Colorectal Cancer (CRC)
1 sites across 1 states
California1
  • Joshua Demb, PhD, MPH · PRINCIPAL_INVESTIGATOR · University of California, San Diego

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults ages 45-49 with EHR documentation indicating that the patient has an assigned primary care provider at UCSD Health
≥1 UCSD Health System health visit within the last year
Resides in San Diego or Imperial County
Currently not up to date with CRC screening
Insured by private, public or other health insurance.

Exclusion

Up-to-date with screening
Prior history of colonic disease, including inflammatory bowel disease, one or more colorectal neoplastic polyps (i.e., adenomas) or colorectal cancer.
Prior history of colectomy
Lack of health insurance
  • Proportion of Colorectal cancer screening completionWithin 12 months of randomization

    The proportion of individuals who complete any colorectal cancer screening test recommended by US Preventive Services Task Force (colonoscopy, FIT, Cologuard, Sigmoidoscopy or CT Colonography)